Full Press Release Details
argenx announces private placement of 2,703,000 new shares for an aggregate amount of €30 million with institutional investors.
ARGX
argenx announces private placement of 2,703,000 new shares for an aggregate amount of €30 million with institutional investors
Key Takeaway: argenx announces private placement of 2,703,000 new shares for an aggregate amount of €30 million with institutional investors
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+42%
120-day peak, hindsight
Typical move
4%
average across 14 past catalysts
Lead asset
Empasiprubart
Phase 2 · Dermatomyositis